Forte Capital LLC ADV Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Forte Capital LLC ADV increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,203 shares of the healthcare conglomerate’s stock after acquiring an additional 44 shares during the quarter. Forte Capital LLC ADV’s holdings in UnitedHealth Group were worth $1,160,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Red Cedar Investment Management LLC lifted its position in UnitedHealth Group by 4.9% during the fourth quarter. Red Cedar Investment Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock valued at $3,460,000 after purchasing an additional 306 shares in the last quarter. Charles Carroll Financial Partners LLC increased its holdings in shares of UnitedHealth Group by 4.6% in the fourth quarter. Charles Carroll Financial Partners LLC now owns 5,706 shares of the healthcare conglomerate’s stock worth $3,004,000 after purchasing an additional 250 shares during the last quarter. Royal Fund Management LLC grew its holdings in UnitedHealth Group by 5.3% during the 4th quarter. Royal Fund Management LLC now owns 5,458 shares of the healthcare conglomerate’s stock valued at $2,874,000 after buying an additional 273 shares in the last quarter. Todd Asset Management LLC grew its holdings in shares of UnitedHealth Group by 5.6% in the fourth quarter. Todd Asset Management LLC now owns 70,607 shares of the healthcare conglomerate’s stock valued at $37,172,000 after purchasing an additional 3,760 shares in the last quarter. Finally, AJOVista LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $247,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock traded down $0.52 during trading on Friday, reaching $492.45. The company had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The firm has a 50-day simple moving average of $482.32 and a 200-day simple moving average of $512.76. The company has a market cap of $453.09 billion, a price-to-earnings ratio of 30.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the company posted $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Analyst Ratings Changes

UNH has been the subject of several recent research reports. Piper Sandler lifted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Bank of America restated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. TD Cowen dropped their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Barclays increased their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $570.05.

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.